A lightweight large language model for regulatory affairs translation in pharmaceutical industry

8.4
来源: Nature 关键字: AI drug discovery
发布时间: 2025-10-31 03:53
摘要:

PhT-LM is a novel lightweight large language model developed to enhance the translation of regulatory affairs documents in the pharmaceutical industry. By utilizing advanced techniques such as retrieval-augmented generation, it significantly improves translation quality and reduces costs associated with traditional translation methods. The model has shown superior performance in both English-Chinese and Chinese-English translation tasks, making it a valuable tool for pharmaceutical companies navigating complex regulatory environments.

原文: 查看原文

价值分投票

评分标准

新闻价值分采用0-10分制,综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。 评分越高,表示该新闻的价值越大,越值得关注。

价值维度分析

domain_focus

1.0分+1.0分+重点关注领域符合度

business_impact

1.0分+商业影响力

scientific_rigor

1.5分+具体实验数据支持

timeliness_innovation

1.5分+技术创新

investment_perspective

2.5分+早期研发阶段

market_value_relevance

1.0分+市场价值相关性

team_institution_background

0.5分+团队背景

technical_barrier_competition

1.0分+技术壁垒

关键证据

PhT-LM achieved a BLEU-4 mean score of 36.018 and a CHRF mean score of 58.047.
The model significantly reduces translation costs and improves efficiency.
It is designed specifically for regulatory affairs, addressing industry-specific challenges.

真实性检查

AI评分总结

PhT-LM is a novel lightweight large language model developed to enhance the translation of regulatory affairs documents in the pharmaceutical industry. By utilizing advanced techniques such as retrieval-augmented generation, it significantly improves translation quality and reduces costs associated with traditional translation methods. The model has shown superior performance in both English-Chinese and Chinese-English translation tasks, making it a valuable tool for pharmaceutical companies navigating complex regulatory environments.

评论讨论

发表评论